FIP set up a group of experts from across pharmaceutical practice, science and education and workforce development, representatives of the Regional Pharmaceutical Forums and individuals with specific expertise in NCDs (initially, diabetes, but other experts will be invited) and in the development and review of this programme and its deliverables, to ensure their quality, plurality and robustness.
This Advisory Group will also include representatives from external organisations focusing on specific disease areas, such as the International Diabetes Federation, or the International Primary Care Respiratory Group. Information about these organisations can be found under the respective disease area tabs of this website.
The roles and responsibilities of this group include:
- Providing expert advice on clinical contents, structure, and relevance to pharmacy practice of the programme handbooks on specific diseases.
- Providing expert advice and reviewing the programme implementation guidelines, indicators and evaluation strategies for the implementation of the programmes at country level.
- Providing expert advice on the development of training modules.
